PharmaTox
The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
News
-
New article in Clinical Epigenetics!
June 30, 2022 5:22 PM
PharmaTox researchers have published a new article, "Low reliability of DNA methylation across Illumina Infinium platforms in cord blood: implications for replication studies and meta-analyses of prenatal exposures", in Clinical Epigenetics. Read it here.
-
New paper from PharmaTox researchers!
June 26, 2022 2:23 PM
PharmaTox researchers have published a new paper in Toxicology and Applied Pharmacology: "Paracetamol perturbs neuronal arborization and disrupts the cytoskeletal proteins SPTBN1 and TUBB3 in both human and chicken in vitro models". Read it here.
-
Disputation: Gerd Marie Eskerud Harris
June 7, 2022 2:20 PM
PharmaTox doctoral candidate Gerd Marie Eskerud Harris defends her thesis "Migraine pharmacotherapy during pregnancy: Utilization patterns and associations with child neurodevelopment" for the degree of Philosophiae Doctor.
-
New article in JAMA Network Open!
June 7, 2022 2:17 PM
PharmaTox researchers set out to answer the question "Is prenatal exposure to triptans associated with an increased risk of attention-deficit/hyperactivity disorder (ADHD) in offspring?".
-
PharmaTox-video med Geir Kjetil Sandve og Harald Eia
Apr. 6, 2022 7:01 AM
Harald Eia lurer på om det er sånn at man kjører masse data inn i datamaksinen, og så finner man at barnet får tannstein dersom mor brukte briller i svangerskapet. Geir Kjetil Sandve svarer.
